Faculty of Medicine

New therapy resistance mechanism in malignant melanomas

Treatment for even advanced tumours is becoming better and better thanks to the modern therapies available today. Sooner or later, however, many patients start to develop a resistance to these therapies and the disease continues to take hold. The ability to understand these mechanisms could therefore be crucial to developing new forms of treatment. With the help of the Clinic for Dermatology, an international research team has been able to define a unique resistance mechanism that does not originate directly from the tumour cells themselves.